Abstract

The malaria parasite Plasmodium falciparum undergoes closed mitosis, which occurs within an intact nuclear envelope, and differs significantly from its human host. Mitosis is underpinned by the dynamics of microtubules and the nuclear envelope. To date, our ability to study P. falciparum mitosis by microscopy has been hindered by the small size of the P. falciparum nuclei. Ultrastructure expansion microscopy (U-ExM) has recently been developed for P. falciparum, allowing the visualization of mitosis at the individual nucleus level. Using U-ExM, three intranuclear microtubule structures are observed: hemispindles, mitotic spindles, and interpolar spindles. A previous study demonstrated that the mini-chromosome maintenance complex binding-protein (MCMBP) depletion caused abnormal nuclear morphology and microtubule defects. To investigate the role of microtubules following MCMBP depletion and study the nuclear envelope in these parasites, we developed the first nuclear stain enabled by U-ExM in P. falciparum. MCMBP-deficient parasites show aberrant hemispindles and mitotic spindles. Moreover, anaphase chromatin bridges and individual nuclei containing multiple microtubule structures were observed following MCMBP knockdown. Collectively, this study refines our understanding of MCMBP-deficient parasites and highlights the utility of U-ExM coupled with a nuclear envelope stain for studying mitosis in P. falciparum.

Highlights

  • Published: 6 November 2021Malaria is estimated to cause over 400,000 deaths annually

  • We demonstrate that BODIPY TRc is the first Plasmodium nuclear envelope stain that is enabled by Ultrastructure Expansion Microscopy (U-ExM)

  • The development of U-ExM and its application to P. falciparum parasites have allowed us to understand the functions of proteins and processes of P. falciparum to a level of detail not previously possible

Read more

Summary

Introduction

Malaria is estimated to cause over 400,000 deaths annually. These deaths are predominantly in young children, and are caused by the unicellular protozoan pathogen. Resistance against frontline antimalarials has emerged in many parts of the globe and is spreading [2–6]. There is no highly effective vaccine against malaria, highlighting the need to develop new therapeutic interventions for ongoing and future control of this disease. One therapeutic strategy is the drug inhibition of DNA/RNA replication, and/or cell division, a method that is commonly used for the control of bacterial [7] and viral diseases [8], along with many types of cancer [9]. The distinctive division method of P. falciparum compared to its human host makes this an attractive strategy for P. falciparum drug design, yet no current antimalarials directly target

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call